🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Had a fantastic experience presenting my findings on real world outcomes of Pembrolizumab vs Cetuximab based therapy in R/M HNSCC at #ASC024 Grateful for the valuable feedback and discussions with experts in the field. Special thanks to Gilberto de Castro Junior for his valuable feedback

More from the #ASCO24 Plenary Session: NADINA results: Neoadjuvant Ipi + Nivo w/ the possibility of additional adjuvant therapy yields superior EFS compared w/ adjuvant Nivo alone in pts w/ macroscopic stage III #melanoma: brnw.ch/21wKmRM #ASCODailyNews #melsm

Initial thoughts I will bring back to clinic from LAURA and ADRIATIC from #ASCO24 #lcsm

NICHE-2 published in NEJM —what an elegant work from super star Myriam Chalabi and senior John Haanen ! Study presented #ESMO22 and started the hashtag #ChalabiPlot => near 100% pathologic response in dMMR colon cancer! OncoAlert

Lifileucel, autologous tumor infiltrating lymphocyte (TIL) cell therapy) in NSCLC post-IO Cancer Discovery. 36d from collection to TIL infusion. RR 21.4% (6/28), including 1 ongoing at 26+ months. Expected Flu/Cy & TIL toxicity but 2 deaths from adverse events. aacrjournals.org/cancerdiscover…

Feels way more complicated than this (esp with TKI/sequencing) but a 2024 #NSCLC management algorithm for boards #lcsm #MedTwitter #OncTwitter

It has been truly a great week at ASCO -AACR Methods in Clinical Cancer Research Workshop in La Jolla, CA. #PDG-06 is the best.

A big THANK YOU to our wonderful group of patient advocates, Jill Feldman Manju George MVSc PhD Rectal Cancer Survivor and our statisticians (Dr. Redman in the photo) for helping us to design better trials! AACR ASCO Methods of Clinical Cancer Research Workshop, La Jolla, CA #VailWorkshop Julie Vose

Just wrapped up an incredible week at the ASCO-AACR Methods in Clinical Cancer Research Workshop (#VailWorkshop) in La Jolla, CA. Leaving inspired with new ideas and grateful for the experience alongside my co-fellow Dr. Hyun Lee. Proud to represent VCU Massey Comprehensive Cancer Center! Dr. Rob Winn

2015 vs 2024 National Comprehensive Cancer Network (NCCN) guidelines for Advanced Bladder Cancer Remarkable how far we have come in 10 years as we have improved our treatment options for better patient outcomes in BCa 🧡Bladder Cancer Advocacy Network #BCANTT24

Great advice! Preparing in advance really sets you up for success as a new attending and help time managment. Thanks for sharing these tips!

Honored to be invited to the FDA White Oak campus! ☺️ Huge thanks to Drs. Pazdur Jennifer Gao Timil Patel, MD Tatiana Prowell, MD @SuparnaWedam for sharing your inspiring journeys to the #FDA And if you know me, you know how much I love #networking 🫣 FDA Oncology ASCO #radonc

FDA-approved EGFR inhibitors in lung cancer! #LungCancer #EGFR #Oncology OncoAlert AACR IASLC

The ASCO virtual mentoring program (VMP) is now accepting applications; this is a great opportunity for trainees. This program was career-changing for me! Consider applying Sara Tolaney Dana-Farber’s Breast Oncology Center OncoAlert asco.smapply.org/prog/2025-26_a…

My Top Lung Cancer Trials of 2024 #LCSM OncoAlert The Cancer News Happy New Year !!! 1. LAURA: In this phase-3 trial, pts with unresectable EGFR-mutated stage III NSCLC were randomized to osimertinib or placebo post chemo-RT ➡️↑ PFS with Osimertinib bit.ly/4iZGUXt

Look no further to learn which battlefront needs the most help. Hint: it isn’t prostate cancer.

I trust the day is coming when all MEDICAL ONCOLOGISTS will stand up and say enough is enough for TACE.

Top 10 GI Trials – ASCO 2025 The biggest GI breakthroughs you must track this year! 🧬 ATOMIC – Atezolizumab + FOLFOX in stage III MSI-H colon 🛡️ MATTERHORN – Durvalumab + FLOT in gastric/GEJ 🧪 DYNAMIC-III – ctDNA-guided chemo in colon 💉 DESTINY-Gastric04 – T-DXd vs RAM+PTX

Blown away by these amazing IMG Oncology leaders sharing their journeys! Their stories hit home. Excited to connect with IMG Oncologists and keep the inspiration going. #IMGOnc #Oncology #ASCO25

Every oncologist is a patient advocate. Right treatment. Right time. For every patient. #ASCO25 #Oncology #CancerCare #AccessMatters @oncoalert ASCO Toni Choueiri, MD Emre Yekedüz 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Petros Grivas TwoOncDocs Oncology Brothers LARVOL Vivek Subbiah, MD Eric J. Small, MD, FASCO American Cancer Society World Health Organization (WHO)